GlassScriptPhysician profile
Sean N Pitale
NPI 1225289952
$7,632.85
in general payments reported to CMS, 2019-2025
18 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $858 · 2020: $33.68 · 2021: $1,224 · 2022: $3,282 · 2023: $390 · 2024: $578 · 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,713 · Travel and Lodging: $515 · Education: $7.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.98 |
| Travel and Lodging | $514.66 |
| Education | $7.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,230.17 | 2019-2025 | Hydrus Microstent, Tryptyr, Total30 |
| Johnson & Johnson Vision Care, INC. | $1,104.93 | 2019-2023 | Acuvue |
| Notal Vision, INC. | $937.81 | 2022 | |
| Bausch & Lomb Americas INC. | $831.67 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Biotissue Holdings INC. | $824.67 | 2021-2025 | |
| Oyster Point Pharma, INC. | $472.84 | 2022-2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $386.54 | 2019-2025 | |
| Allergan, INC. | $382.33 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $368.06 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $360.66 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $209.06 | 2021-2023 | |
| Astellas Pharma US INC | $144.37 | 2023 | |
| Eyevance Pharmaceuticals LLC | $129.03 | 2021 | |
| Coopervision INC. | $102.38 | 2022 | |
| Abbvie INC. | $97.04 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $18.92 | 2021 | |
| Dompe US, INC. | $17.82 | 2022 | |
| Glaukos Corporation | $14.55 | 2025 | Idosetr, Istent Infinite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Pitale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.